Rick Bright details mismanaged pandemic response, warns of drugs, vaccine supply problems down the road; HHS pushes back
In wide-ranging congressional testimony, the ousted head of an agency at the center of the federal government’s Covid-19 vaccine and treatment response criticized the Trump administration for a slow-footed federal response that could resound throughout the course of the pandemic.
“I believe we could have done better,” Rick Bright, former chief of the Biomedical Advanced Research and Development Authority (BARDA), told a House subcommittee. “We don’t have the right leadership for this response and we don’t have the right plan for this response.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.